A group of top scientists in Saudi Arabia is warning that Covid mRNA "vaccines" are having a devastating impact on male fertility.
The warning comes as several nations around the world have reported birth rate plunges that are way below sustainable levels.
Now, a new study conducted by researchers affiliated with King Abdulaziz University in Saudi Arabia is warning that Covid mRNA injections are causing serious harm to fertility rates among men.
The team of researchers was led by Dr. Mohammed Ahmed Alkireidmi and corresponding author Firoz Anwar, a pharmaceutical doctor.
The study discovered that male infertility has increased significantly following the COVID-19 pandemic.
The researchers found that men became infertile after receiving a Covid mRNA injection.
In the study's paper, published in the renowned journal Current Medicinal Chemistry, the researchers explain that the immunogenic effects of IgA antibodies interacting with key sperm-related proteins cause men to become infertile.
It suggests that anti-sperm antibodies (ASA) produced after vaccination contribute to reduced sperm motility, altered liquefaction times, and abnormal sperm morphology.
By investigating these molecular interactions, the study aims to establish a causal link between COVID-19-related immune responses and male infertility.
The study was a dual-center, case-control, prospective study conducted at King Abdulaziz University.
Researchers collected 133 semen samples from males with normal sperm parameters.
The study analyzed sperm motility, liquefaction time, and abnormal sperm percentages across different age groups.
It also conducted an in silico molecular modeling analysis to investigate interactions between IgA antibodies and key sperm-associated proteins:
The Saudi-based investigators used the molecular docking process for the analysis.
They examined interaction distances, amino acid variations, and bond length alterations to determine how IgA might interfere with sperm function.
The study found a peak in male infertility among vaccinated men between ages 31-40 (50%).